Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SEEDS Capital
Singapore, Singapore
- Ownership
- Private
- Development stage
- Other
01
Overview
SEEDS Capital is a government-backed venture capital investor, not a drug/platform developer, and does not have its own clinical-stage assets. It co-invests in early-stage tech and biomedical startups; some portfolio companies are in biotech, health tech, and biomedical sciences, but SEEDS Capital itself is not a therapeutics developer.[3][6][8][9]
- Industry
- Investors
02
Partnerships
Jungle VenturesWavemaker PartnersHeritas Capital ManagementOpenspace VenturesNSG VenturesAdvanced MedTech HoldingsClavystBioCoronet VenturesKurma PartnersMassMutual VenturesTrinity Innovation Bioventure SingaporeVickers Venture PartnersTrendlines Medical Singapore
Beyond the preview
Go deeper on SEEDS Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SEEDS Capital.